Out of 432 conventional ameloblastoma cases, 316 (73.15%) had BRAF mutation, while other variants (including unicystic, desmoplastic, and peripheral) reported that 80.33% (98 out of 122 patients) also had the mutation. The gene discussed is BRAF; the disease is ameloblastoma.